AVIR
Closed
Atea Pharmaceuticals inc
3.6
0.0 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.6
Day's Range: 3.535 - 3.65
Send
sign up or login to leave a comment!
When Written:
3.35
Atea Pharmaceuticals Inc is a biopharmaceutical company that focuses on discovering and developing antiviral therapeutics for the treatment of life-threatening viral infections. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Atea Pharmaceuticals' lead product candidate is AT-527, an oral direct-acting antiviral (DAA) agent for the treatment of COVID-19. The company is also developing other antiviral candidates for the treatment of hepatitis C virus (HCV) and respiratory syncytial virus (RSV).
In addition to its drug development programs, Atea Pharmaceuticals has partnerships with several leading pharmaceutical companies and research institutions. The company has received funding from various sources, including venture capital firms and government agencies.
Atea Pharmaceuticals is led by a team of experienced executives and scientists with a track record of success in drug discovery and development. The company is committed to advancing innovative therapies for viral diseases that have a significant impact on global health.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Atea Pharmaceuticals' lead product candidate is AT-527, an oral direct-acting antiviral (DAA) agent for the treatment of COVID-19. The company is also developing other antiviral candidates for the treatment of hepatitis C virus (HCV) and respiratory syncytial virus (RSV).
In addition to its drug development programs, Atea Pharmaceuticals has partnerships with several leading pharmaceutical companies and research institutions. The company has received funding from various sources, including venture capital firms and government agencies.
Atea Pharmaceuticals is led by a team of experienced executives and scientists with a track record of success in drug discovery and development. The company is committed to advancing innovative therapies for viral diseases that have a significant impact on global health.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








